Troy Cox
Director Board of Directors at Zymeworks Inc
Based in Miami Beach, United States
7-day free trial · no credit card
Seniority
Director
Department
General Business & Management
Location
Miami Beach
Industry
Biotechnology Research
Company size
295
Contact information
Reveal Troy's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
t•••••••@zymeworks.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Troy Cox
Troy Cox, former CEO of Foundation Medicine, is working to make a difference in patients’ lives by serving on the boards of non-profits and innovative growth companies in the Biotech, Genetics, Diagnostic, and HealthTech industries- Independent Board Director of Dream Foundation (non-profit) since 2015 to Present “Giving life to final dreams” - Board Director, President and CEO of Foundation Medicine from early 2017 through the acquisition by Roche valuing (NASDAQ FMI) at $5.3 billion - Independent Board Director of Massachusetts BioTechnology Council (MassBio) 2018 to 2022 - Independent Board Director of Zymeworks (NYSE ZYME) since June 2019 to Present “Building better biologics” - Independent Chairman and Board Director of SOPHiA Genetics (NASDAQ:SOPH) since July 2019 to Present (Chairman since Feb 2020). IPO July 2021. “Democratizing data driven medicine” - Independent Board Director of LetsGetChecked (Series E) since Oct 2019 to Present (Chairman/Vice Chairman May 2020 to Nov 2022) “Empowering people to use at home health testing” - Independent Board Director of Somalogic Inc.(NASDAQ: SLGC) since April 2021 to Present (Executive Chairman Oct 2022 to March 2023) “Transforming research and healthcare with industry-leading proteomics"- Independent Board Director of Biosplice (Series B) since April 2021 to Present. Regenerative medicine Prior to Foundation Medicine, Troy served as Senior Vice President and Officer at Genentech, where he led US BioOncology for a period of unprecedented growth to over $12 billion, participating in the launch of nearly half of the products from the world’s oncology leader, while accountable to help steer the Roche Genentech R&D portfolio. Before Genentech, Troy held executive and senior roles of increasingly broad accountabilities including President UCB BioPharmaceuticals, Senior Vice President Sanofi-Aventis and diverse foundational roles at Schering-Plough. Troy received his MBA at the University of Missouri and BBA in Finance from the University of Kentucky. Troy is a proud father with his husband residing primarily in Miami Beach and a frequent visitor to Boston, San Francisco, Seattle, NYC, Geneva, Dublin and London.
Decision-makers
Other people at Zymeworks Inc
Build a list of verified contacts at Zymeworks Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Troy
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime